Mitchell L. Krassan
2017
In 2017, Mitchell L. Krassan earned a total compensation of $1.2M as Executive Vice President and Chief Strategy Officer at TherapeuticsMD, a 162% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $171,000 |
|---|---|
| Option Awards | $671,064 |
| Salary | $360,000 |
| Other | $19,346 |
| Total | $1,221,410 |
Krassan received $671.1K in option awards, accounting for 55% of the total pay in 2017.
Krassan also received $171K in non-equity incentive plan, $360K in salary and $19.3K in other compensation.
Rankings
In 2017, Mitchell L. Krassan's compensation ranked 8,023rd out of 14,666 executives tracked by ExecPay. In other words, Krassan earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,023 out of 14,666 | 45th |
Division Manufacturing | 3,018 out of 5,772 | 48th |
Major group Chemicals And Allied Products | 988 out of 2,075 | 52nd |
Industry group Drugs | 772 out of 1,731 | 55th |
Industry Pharmaceutical Preparations | 609 out of 1,333 | 54th |
Source: SEC filing on April 27, 2018.
Krassan's colleagues
We found four more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2017.